Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 22 Dec 21 1-A POS Offering $20M in Equity
-
30 Sep 21 1-A POS Offering $20M in Equity
- 20 Jan 21 1-A POS Offering $20M in Equity
- 22 Dec 20 1-A POS Offering $20M in Equity
- 6 Nov 19 QUALIF Notice of qualification
- 29 Oct 19 1-A/A Offering $20M in Equity
- 29 Oct 19 1-A-W Offering statement withdrawal
- 17 Oct 19 1-A/A Offering $20M in Equity
- 7 May 19 1-A Offering $10.02M in Equity
Acqusalut similar filings
Filing view
External links
Exhibit 8
Consent of Independent Registered Public Accounting Firm
We consent to the inclusion in this Registration Statement of XEME Biopharma Holdings, Inc. on Amendment No. 3 to Form 1-A to be filed on or about September 30, 2021, of our report dated May 3, 2021, except for those items affected by the restatement discussed in Note 13, which are dated September 29, 2021, on our audit of the financial statements of XEME Biopharma Holdings, Inc. as of December 31, 2020 and 2019, and for the years ended December 31, 2020 and 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Benjamin & Ko,
Santa Ana, CA
September 30, 2021